Cornelia

The Carasent Group has officially achieved certification according to ISO14001, marking a significant step forward in the company’s commitment to sustainability and responsible business practices. The certification highlights Carasent's efforts to minimize its environmental impact while encouraging its partners and clients to adopt greener practices.

Frelsesarmeen is embarking on a transformative digital journey by collaborating with Carasent Norway to introduce the Electronic Health Record (EHR) system, Ad Curis, in its addiction care and recovery clinics across Norway.

Västra Götalands Regionen (VGR) has chosen Medrave AB, a subsidiary of Carasent Group, to integrate the Medrave M4 software with their newly adopted Electronic Health Record (EHR) system, Millennium.

Carasent is delighted to welcome Stefan Jernberg as the group's new Chief Compliance Officer. Stefan brings a wealth of experience and expertise in compliance, having a strong background in software development, MedTech, and extensive knowledge of regulatory frameworks.

Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to implement the EHR system Metodika EPM at Volvat’s hospitals and clinics in Norway. The annual revenue from the contract is estimated to 7-9 MNOK, where the majority is recurring revenue (“ARR”)

Carasent ASA is set to embark on an exciting new phase as it updates its long-term financial targets for revenue growth and profitability. The detailed presentation will take place today at the Capital Markets Day (CMD).

The board of directors of Carasent ASA has today appointed Daniel Öhman as the Company’s new Chief Executive Officer (CEO). He will succeed Dennis Höjer, who has been CEO since December 2020. Öhman will start no later than 2 January 2023.